At Taloja
Alkem Laboratories announced that US FDA had conducted an inspection at the Company's Bioequivalence facility located at Taloja, India from 10 July, 2017 to 14 July, 2017. At the end of the inspection, no Form 483 was issued.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
